Lithuania is one of Europe’s fastest-growing life sciences ecosystems, generating around 2.7 % of national GDP and expanding at 22–25 % annually, with a goal to reach 5% by 2030.
Vilnius is a hub for Biotech and MedTech, supported by a highly skilled workforce, modern infrastructure, a business-friendly environment, and sustainable energy solutions. These strengths make the city an attractive destination for international R&D and biomanufacturing investments.
300+
life sciences companies in Vilnius
Source: Life Sciences in Lithuania, 2024 (Invest Lithuania)
90 %+
biotech exports to 100+ countries, including US (29 %) & Germany (23 %)
Source: Life Sciences in Lithuania, 2024 (Invest Lithuania)
CRISPR
gene-editing breakthrough by Virginijus Šikšnys
EMBL
Partnership Institute at the Vilnius University Life Sciences Center
Source: Life Sciences in Lithuania, 2024 (Invest Lithuania)
1,000+
talents brought together by VU Life Sciences Center
Source: Life Sciences in Lithuania, 2024 (Invest Lithuania)
24,600
researchers engaged in MISTI, EMBL and other networks
Source: Life Sciences in Lithuania, 2024 (Invest Lithuania)
63 %
female representation among Lithuania’s scientists and engineers
Sources: LT Fintech Report 2024-2025, Invest Lithuania Fintech Survey 2024
#3 in OECD
for biotechnology R&D spending intensity
Source: Labiotech, 2024
Business Advantages
Companies in Vilnius can take advantage of national incentives such as Invest LT+, offering cashback on employment and capital investments to accelerate growth.
Large-scale, innovation-driven projects may access long-term financing through the Billion for Business programme.
High value-added tech and digitalization projects in Vilnius County can receive up to €10M in funding via the Change programme.
Lithuania’s national health-data portal, managed by the State Data Agency (VDA), is publicly accessible. Researchers, companies, and public institutions can apply online to access and reuse large-scale electronic health records and national registries.
Vilnius City Innovation Industrial Park (VCIIP) is Lithuania’s first industrial park dedicated to life sciences. Covering 24 hectares, it offers modern lab and manufacturing facilities, green energy solutions, easy public transport access, and tax incentives for investors.
Located in Vilnius, NTP operates the VCIIP and develops innovation infrastructure, bringing together biotech, MedTech, and IT companies, as well as startups. The park offers R&D labs, a business incubator, and technology development facilities, fostering commercialization and academic collaboration.
Valued at over €7 billion, Bio City is set to become the largest biotech complex in Europe. The campus will integrate research, manufacturing, and innovation infrastructure, focusing on biomanufacturing, sustainable technologies, and high-value product development.
One of the region’s leading research hubs, Santara Science Valley unites five scientific institutes, four private R&D centers, and three GMP manufacturing facilities. It specializes in medicine, chemistry, and biochemistry, with strong industry partnerships enabling rapid commercialization of innovations.
Valued at around €50 million, Celltechna is the first gene therapy center of its kind in the Baltics. It focuses on the development, clinical translation, and commercial application of advanced gene therapies, positioning Vilnius as a leading hub for cutting-edge biotech innovation.
STEM & Life Sciences Hub
Vilnius attracts top researchers, scientists, and highly skilled specialists. The city is home to Vilnius University’s Life Sciences Center, an EMBL-accredited institution uniting biochemistry, biotechnology, and biosciences institutes, driving world-class research in genetics, molecular biology, and medicine.
Schedule your strategic site visit
Let’s plan a tailored site visit for your team to experience Vilnius. Get matched with decision-makers, ecosystem leaders, and strategic partners – on your timeline.
